Fabrication and efficacy assessment of combination of brimonidine and ivermectin for treatment of papulopustular rosacea.

Eight-week treatment with the combination of brimonidine 0.33% and ivermectin 1% was shown to be effective for improvement of erythema and inflammatory lesions in mild to moderate papulopustular rosacea.